Comparative Clinical Efficacy of Septoaponeurotic Junctional Thickening Versus Bridge Technique in Double-Eyelid Blepharoplasty.

Authors

Tianshi Li, Wentao Fang, Huaxin Hu, Jian Hao

Published in

Aesthetic plastic surgery. Jul 28, 2026. Epub Jul 28, 2026.

Abstract

This study compared the clinical efficacy, safety, and fold stability of the septoaponeurotic junctional thickening (SAJT) method and the bridge technique (BT) in double-eyelid blepharoplasty.
This retrospective analysis included 82 patients aged 18-40 years from a prospectively collected randomized comparative cohort who underwent primary double-eyelid surgery between June 2023 and October 2024. Patients had been assigned to the SAJT group (n = 42) or the BT group (n = 40). Outcomes included operative time, edema resolution, complications, objective esthetic outcomes at 6 and 12 months, dynamic eyelid movement score, and patient satisfaction.
The SAJT group had a significantly shorter operative time and faster postoperative edema resolution than the BT group (P < 0.05). Hematoma was numerically less frequent in the SAJT group, without a significant between-group difference. At 6 months, the overall improvement rates were comparable between groups (P > 0.05), whereas the dynamic movement score was higher in the SAJT group (P < 0.05). Patient satisfaction at 6 months was similar between groups (P > 0.05). Objective crease attenuation or disappearance was observed in three of 42 SAJT cases and two of 40 BT cases at 6 months. At 12 months, 36 patients in the SAJT group and 33 in the BT group remained in follow-up. The overall improvement rates remained comparable at 12 months (P > 0.05), and the dynamic movement score remained higher in the SAJT group (P < 0.05).
Both techniques achieved favorable outcomes. SAJT was associated with greater operative efficiency and better dynamic fold performance, whereas BT provided comparable short-term and 12-month fold stability. Technique selection should be individualized according to eyelid anatomy and surgical goals.
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

PMID:
42521782
Bibliographic data and abstract were imported from PubMed on 29 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.